1. Home
  2. HUT vs AGIO Comparison

HUT vs AGIO Comparison

Compare HUT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUT
  • AGIO
  • Stock Information
  • Founded
  • HUT 2011
  • AGIO 2007
  • Country
  • HUT United States
  • AGIO United States
  • Employees
  • HUT N/A
  • AGIO N/A
  • Industry
  • HUT Finance: Consumer Services
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUT Finance
  • AGIO Health Care
  • Exchange
  • HUT Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • HUT 1.7B
  • AGIO 1.4B
  • IPO Year
  • HUT N/A
  • AGIO 2013
  • Fundamental
  • Price
  • HUT $21.87
  • AGIO $36.07
  • Analyst Decision
  • HUT Strong Buy
  • AGIO Buy
  • Analyst Count
  • HUT 14
  • AGIO 6
  • Target Price
  • HUT $26.64
  • AGIO $58.60
  • AVG Volume (30 Days)
  • HUT 6.9M
  • AGIO 524.8K
  • Earning Date
  • HUT 08-12-2025
  • AGIO 07-31-2025
  • Dividend Yield
  • HUT N/A
  • AGIO N/A
  • EPS Growth
  • HUT N/A
  • AGIO N/A
  • EPS
  • HUT N/A
  • AGIO 11.45
  • Revenue
  • HUT $132,459,000.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • HUT $74.79
  • AGIO $22.30
  • Revenue Next Year
  • HUT $116.78
  • AGIO $219.19
  • P/E Ratio
  • HUT N/A
  • AGIO $3.15
  • Revenue Growth
  • HUT 0.24
  • AGIO 25.96
  • 52 Week Low
  • HUT $8.73
  • AGIO $23.42
  • 52 Week High
  • HUT $31.95
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • HUT 69.22
  • AGIO 62.76
  • Support Level
  • HUT $17.03
  • AGIO $32.87
  • Resistance Level
  • HUT $18.88
  • AGIO $35.85
  • Average True Range (ATR)
  • HUT 1.25
  • AGIO 1.38
  • MACD
  • HUT 0.31
  • AGIO -0.05
  • Stochastic Oscillator
  • HUT 90.81
  • AGIO 76.58

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: